PMC:7497282 / 109617-110397 JSONTXT

Annnotations TAB JSON ListView MergeView

    MyTest

    {"project":"MyTest","denotations":[{"id":"32741232-25316823-29927553","span":{"begin":389,"end":392},"obj":"25316823"},{"id":"32741232-31096971-29927554","span":{"begin":439,"end":442},"obj":"31096971"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Modeling the polio endgame and particularly the potential for OPV restart can also motivate the exploration of investments in developing new, non-vaccine risk management strategies for the polio endgame. For example, the results of modeling the reveal under-vaccinated subpopulations can lead to the development of better evaluation methods to monitor vaccine delivery (e.g. GPS tracking [246]), surveillance (e.g. GIS settlement mapping [247]), and/or other interventions. As with vaccines, the extent to which countries and donors are willing to invest in future risk management tools and strategies will determine their development pathway and ultimate use. The willingness to support modeling studies will also determine the demand and resources available for future modeling."}

    2_test

    {"project":"2_test","denotations":[{"id":"32741232-25316823-29927553","span":{"begin":389,"end":392},"obj":"25316823"},{"id":"32741232-31096971-29927554","span":{"begin":439,"end":442},"obj":"31096971"}],"text":"Modeling the polio endgame and particularly the potential for OPV restart can also motivate the exploration of investments in developing new, non-vaccine risk management strategies for the polio endgame. For example, the results of modeling the reveal under-vaccinated subpopulations can lead to the development of better evaluation methods to monitor vaccine delivery (e.g. GPS tracking [246]), surveillance (e.g. GIS settlement mapping [247]), and/or other interventions. As with vaccines, the extent to which countries and donors are willing to invest in future risk management tools and strategies will determine their development pathway and ultimate use. The willingness to support modeling studies will also determine the demand and resources available for future modeling."}